Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
News > Business News
Audio By Carbonatix
7:00 AM on Thursday, February 20, 2025
The Associated Press
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Feb 20, 2025--
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit in New York City on Thursday, February 27, 2025.
As part of the event, David Moatazedi, President and CEO of Evolus, will host a fireside chat on Thursday, February 27, 2025, from 9:30 AM – 10:00 AM ET. A live webcast of the fireside chat can be accessed on the Investor Relations page of the Evolus website here. A replay of the webcast will remain available for 90 days following the event.
About Evolus, Inc.
Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau ® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse ™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.
Jeuveau ® and Nuceiva ®, are registered trademarks and Evolysse ™ is a trademark of Evolus, Inc.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250220185397/en/
CONTACT: Investors:
Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications
Phone: (248) 202-9267
Email:[email protected]:
Email:[email protected]
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: MEDICAL DEVICES WOMEN FITNESS & NUTRITION OTHER HEALTH HEALTH COSMETICS CONSUMER PHARMACEUTICAL RETAIL
SOURCE: Evolus
Copyright Business Wire 2025.
PUB: 02/20/2025 08:00 AM/DISC: 02/20/2025 08:00 AM
http://www.businesswire.com/news/home/20250220185397/en
